Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

134 ARTÍCULOS , VIENDO DEL 91 AL 105

Towards an earlier diagnosis of Alzheimer's disease presenting with visuospatial disorders (posterior cortical atrophy)

Vighetto A.

Rev Neurol (Paris). 2013 Oct;169(10):687-94. doi: 10.1016/j.neurol.2013.08.001. Epub 2013 Sep 12.

Alzheimer disease: from biomarkers to diagnosis

Dubois B, Epelbaum S, Santos A, Di Stefano F, Julian A, Michon A, Sarazin M, Hampel H.

Rev Neurol (Paris). 2013 Oct;169(10):744-51. doi: 10.1016/j.neurol.2013.07.016. Epub 2013 Sep 13.

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

McGeer PL, McGeer EG.

Acta Neuropathol. 2013 Oct;126(4):479-97. doi: 10.1007/s00401-013-1177-7. Epub 2013 Sep 20.

Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses

Yener GG, Başar E.

Suppl Clin Neurophysiol. 2013;62:237-73. doi: 10.1016/b978-0-7020-5307-8.00020-x.

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases

Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU, Regeniter A, Lindberg RL, Kappos L, Leppert D, Petzold A, Giovannoni G, Kuhle J.

PLoS One. 2013 Sep 20;8(9):e75091. doi: 10.1371/journal.pone.0075091. eCollection 2013.

[The DIAN study]

Shimada H.

Brain Nerve. 2013 Oct;65(10):1179-84.

Serum multivalent cationic pattern: speculation on the efficient approach for detection of Alzheimer's disease

Azhdarzadeh M, Noroozian M, Aghaverdi H, Akbari SM, Baum L, Mahmoudi M.

Sci Rep. 2013 Oct 10;3:2782. doi: 10.1038/srep02782.

Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease

Forlenza OV, Diniz BS, Teixeira AL, Stella F, Gattaz W.

Braz J Psychiatry. 2013 Jul-Sep;35(3):284-94. doi: 10.1590/1516-4446-2012-3505.

Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?

Hu WT, Shaw LM, Trojanowski JQ.

Acta Neuropathol. 2013 Nov;126(5):625-9. doi: 10.1007/s00401-013-1197-3.

Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans

Deguil J, Ravasi L, Auffret A, Babiloni C, Bartres Faz D, Bragulat V, Cassé-Perrot C, Colavito V, Herrero Ezquerro MT, Lamberty Y, Lanteaume L, Pemberton D, Pifferi F, Richardson JC, Schenker E, Blin O, Tarragon E, Bordet R.

Drug Discov Today Technol. 2013 Sep;10(3):e329-42. doi: 10.1016/j.ddtec.2013.03.003.

[Biomarkers of the Alzheimer's disease: concepts and clinical case]

Bier JC.

Rev Med Brux. 2013 Sep;34(4):306-10.

[Early diagnosis of Alzheimer's disease]

Seppälä T, Herukka SK, Remes AM.

Duodecim. 2013;129(19):2003-10.

Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults

Nation DA, Edland SD, Bondi MW, Salmon DP, Delano-Wood L, Peskind ER, Quinn JF, Galasko DR.

Neurology. 2013 Dec 3;81(23):2024-7. doi: 10.1212/01.wnl.0000436935.47657.78. Epub 2013 Nov 13.

Alzheimer's disease: analyzing the missing heritability

Ridge PG, Mukherjee S, Crane PK, Kauwe JS; Alzheimer’s Disease Genetics Consortium.

PLoS One. 2013 Nov 7;8(11):e79771. doi: 10.1371/journal.pone.0079771. eCollection 2013.

The oxidative stress hypothesis in Alzheimer's disease

Padurariu M, Ciobica A, Lefter R, Serban IL, Stefanescu C, Chirita R.

Psychiatr Danub. 2013 Dec;25(4):401-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias